Outpatient surgery to map lymph nodes in mouth and throat cancer
Part of Cancer clinical trials.
This trial studies a planned, same-day (outpatient) surgery approach to find and check cancer spread to nearby lymph nodes in early-stage mouth and throat squamous cell cancer. It may help doctors remove the right lymph nodes and decide on any needed further treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an adult (age 18+) with biopsy-proven mouth or throat (oropharynx) squamous cell cancer within the last month
- Your cancer is early stage: T1 or T2, with no lymph node spread (N0) and no distant spread (M0), and it can be surgically treated
- Your surgeon will perform a detailed scope exam of the nose/throat area to confirm the tumor and its exact “T” stage
- Your surgery plan must be suitable for outpatient (same-day) anesthesia and recovery (ASA I–III, stable)
- You must be able to attend follow-up visits for up to 2 years and understand the study and its monitoring
- You must not have certain exclusions like prior head/neck radiation or prior head/neck surgery, and you must be able to receive the tracer injection used for the lymph-node mapping
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a new surgical reconstruction method can improve outcomes for people with oral cavity or oropharyngeal squamous cell carcinoma (a type of head and neck cancer). The goal is to rebuild the area using a tissue flap while reducing problems where the tissue is taken from.
This trial studies two ways to check whether early oral cavity cancer has spread to nearby neck lymph nodes. It compares sentinel node biopsy versus limited elective neck dissection to see which approach is more useful for people with node-negative tongue or inner-cheek cancers.
This study helps doctors plan surgery more individually for early-stage oral (mouth) squamous cell carcinoma. It focuses on using tumor features found during evaluation to guide surgical decisions, aiming to improve treatment accuracy.
This study tests whether a personalized approach to radiation therapy after surgery, guided by a special lymph node biopsy (sentinel node biopsy), can effectively treat mouth cancer while reducing side effects. It is for people whose cancer is on one side of the mouth and has not spread to the other side of the neck or beyond.
This trial compares two ways of checking whether early oral cavity squamous cell cancer has spread to neck lymph nodes. It tests whether sentinel lymph node biopsy can find spread as well as standard neck dissection, while potentially reducing more extensive surgery for some people.
This Phase 2 trial compares two standard cancer treatments—radiation or surgery through the mouth—for HPV-negative oropharyngeal throat cancer. It aims to find out which approach works better while keeping side effects and quality of life acceptable.
Hear when a new Cancer T1-N0 or T2-N0 of the Oral Cavity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.